Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, safety and pharmacokinetics of
maintenance treatment with 3mg/kg, 6mg/kg or 10mg/kg of TA-650 in combination with
methotrexate (MTX) after three infusions (weeks-0, 2, 6) of 3mg/kg in Rheumatoid Arthritis
(RA) showing an insufficient response to MTX.